Apellis Pharma Reports Exclusive Research Collab With Beam Therapeutics To Apply Base Editing To Discover Novel Therapies For Complement-Driven Diseases
Collaboration combines Apellis’ expertise in complement, a complex biological system, with Beam’s proprietary base editing platform
Companies will collaborate on six research programs directed to tissues